肿瘤靶点和治疗 SCIE

期刊简介预计审稿时间： 较慢,6-12周

OncoTargets and Therapy is an international, peer-reviewed journal focusing on molecular aspects of cancer research, that is, the molecular diagnosis of and targeted molecular or precision therapy for all types of cancer.

The journal is characterized by the rapid reporting of high-quality original research, basic science, reviews and evaluations, expert opinion and commentary that shed novel insight on a cancer or cancer subtype.

Specific topics covered by the journal include:

-Novel therapeutic targets and innovative agents

-Novel therapeutic regimens for improved benefit and/or decreased side effects

-Early stage clinical trials

Further considerations when submitting to OncoTargets and Therapy:

-Studies containing in vivo animal model data will be considered favorably.

-Tissue microarray analyses will not be considered except in cases where they are supported by comprehensive biological studies involving multiple cell lines.

-Biomarker association studies will be considered only when validated by comprehensive in vitro data and analysis of human tissue samples.

-Studies utilizing publicly available data (e.g. GWAS/TCGA/GEO etc.) should add to the body of knowledge about a specific disease or relevant phenotype and must be validated using the authors’ own data through replication in an independent sample set and functional follow-up.

-Bioinformatics studies must be validated using the authors’ own data through replication in an independent sample set and functional follow-up.

-Single nucleotide polymorphism (SNP) studies will not be considered.

OncoTargets and Therapy 是一本国际同行评审期刊，专注于癌症研究的分子方面，即所有类型癌症的分子诊断和靶向分子或精准治疗。

该期刊的特点是快速报道高质量的原创研究、基础科学、评论和评估、专家意见和评论，为癌症或癌症亚型提供新的见解。

该期刊涵盖的具体主题包括：

-新的治疗靶点和创新药物

-用于提高疗效和/或减少副作用的新型治疗方案

-早期临床试验

向 OncoTargets and Therapy 投稿时的进一步考虑：

-包含体内动物模型数据的研究将得到优先考虑。

-组织微阵列分析将不予考虑，除非它们得到涉及多个细胞的综合生物学研究的支持行。

-只有通过全面的体外数据和人体组织样本分析进行验证后，才会考虑生物标志物关联研究。

-利用公开数据（例如 GWAS/TCGA/GEO 等）的研究应增加有关特定疾病或相关表型的知识体系，并且必须使用作者自己的数据通过在独立样本集中复制和功能跟踪进行验证。

-生物信息学研究必须使用作者自己的数据通过在独立样本集中复制和功能跟踪进行验证。

-单核苷酸多态性 (SNP) 研究将不予考虑。

《Oncotargets And Therapy》(肿瘤靶点和治疗)编辑部通讯方式为PO BOX 300-008, ALBANY, NEW ZEALAND, AUCKLAND, 0752。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。